Navigate:

StoreFront / Immunohistochemistry / Antibodies / All Antibodies / BAP1 (BSB-109), MMab

<		Previous Product
		Next Product		>

BAP1 (BSB-109), MMab

Presentation:

Price: $178.50

SKU:	BSB 3300
Antibody type:	Mouse Monoclonal
Clone:	BSB-109
Isotype:	IgG1
Concentrate Dilution:	1:50-1:200
Localization:	Cytoplasmic, Nuclear
Tissue Control:	Testis, TCC, Mesothelioma
Species Reactivity:	Human, Mouse, Rat

DescriptionDocumentationAsk a QuestionPrice Details

Intended Use

For In Vitro Diagnostic Use

Summary and Explanation

BAP1 antibody is a new mouse monoclonal antibody for immunohistochemistry from Bio SB. BAP1 or BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) is a deubiquitinating enzyme that in humans is encoded by the BAP1 gene. Recent studies have shown that BAP1 and its fruit fly homolog, Calypso, are members of the polycomb-group proteins (PcG) of highly conserved transcriptional repressors required for long-term silencing of genes that regulate cell fate determination, stem cell pluripotency, and other developmental processes.

In cancer, BAP1 can function both as a Tumor suppressor and as a metastasis suppressor. Exome sequencing identified inactivating mutations in BAP1 in 47% of Uveal melanomas, and BAP1 mutation have been found to be strongly associated with metastasis. The atypical melanocytic lesions resemble Spitz nevi and have been characterized as “atypical Spitz tumors” (ASTs), although they have a unique histology and exhibit both BRAF and BAP1 mutations.

BAP1 mutations have been identified in aggressive Mesotheliomas with similar mutations as seen in melanomas. Sequencing studies have been used to identify germline mutations in BAP1 in families with genetic predispositions to mesothelioma and melanocytic skin tumors. Mutations in the tumor suppressor gene BAP1 occur in approximately 15% of clear cell renal cell carcinoma cases. Sequencing efforts demonstrated worse outcomes in patients with BAP1 mutated clear cell renal cell carcinoma. Immunohistochemistry for BAP1 is a prognostic biomarker to predict poor oncologic outcomes and adverse clinicopathological features in patients with non-metastatic clear cell renal cell carcinoma. BAP1 assessment using immunohistochemistry on needle biopsy may benefit preoperative risk stratification and guide treatment planning.

Presentation

BAP1 antibody is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.

Synonyms: BAP-1, BAP1, BRCA1 associated protein 1, anti-BAP1, anti BAP1, BAP1 gene product, anti-BRCA1 associated protein 1, anti BRCA1 associated protein 1, anti-BAP1 gene product, anti BAP1 gene product, anti-bap1, anti-bap-1

Specification Sheets

IVD - CE

Safety Data Sheets

SDS

There are currently no questions about this product.
Ask a Question

Option	SKU	Price
Presentation: 3 ml Predilute	BSB 3300	$178.50
Presentation: 7 ml Predilute	BSB 3301	$321.30
Presentation: 15 ml Predilute	BSB 3302	$579.60
Presentation: .1 ml Concentrate	BSB 3303	$196.35
Presentation: .5 ml Concentrate	BSB 3304	$435.75
Presentation: 1 ml Concentrate	BSB 3305	$661.50
Presentation: Control Slides [5]	BSB-9025-CS	$67.00